Either a VEGF-C promoter fragment lacking the NF-κB binding site or mutation of the NF-κB binding site in the VEGF-C promoter region showed no NF-κB activity in either Bmi-1-overexpressing and -silenced glioma cells (Figure 5C). The gene discussed is VEGFC; the disease is glioma.